Greening, D. W., Lee, S. T., Ji, H., Simpson, R. J., Rigopoulos, A., Murone, C., . . . Scott, A. M. (2016). Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways. Oncotarget.
শিকাগো স্টাইলে সাইটেশনGreening, David W., et al. "Correction: Molecular Profiling of Cetuximab and Bevacizumab Treatment of Colorectal Tumours Reveals Perturbations in Metabolic and Hypoxic Response Pathways." Oncotarget 2016.
এমএলএ সাইটেশনGreening, David W., et al. "Correction: Molecular Profiling of Cetuximab and Bevacizumab Treatment of Colorectal Tumours Reveals Perturbations in Metabolic and Hypoxic Response Pathways." Oncotarget 2016.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.